Andere talen Baxter International Inc.

Aandelen

BAX

US0718131099

Beurs gesloten - Nyse Andere beurzen 22:00:02 23-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
41,02 ^USD	+1,53%		+3,80%	+6,10%

23/04	Edwards Lifesciences Corporation : het verhaal gaat verder
11/04	Baxter International Inc. Breidt Farmaceutische portefeuille uit met nieuwe injecteerbare producten in de VS	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Edwards Lifesciences Corporation: The story continues	23/04
Edwards Lifesciences Corporation : La historia continúa	23/04
Edwards Lifesciences Corporation: Fortlaufende Erfolgsgeschichte	23/04
Edwards Lifesciences Corporation: la storia continua	23/04
Edwards Lifesciences Corporation : L’histoire se poursuit	23/04
Exact Sciences Names Aaron Bloomer CFO	15/04
Baxter Expands Pharmaceuticals Portfolio with New Injectable Products in the U.S.	11/04
Baxter International Inc. Expands Pharmaceuticals Portfolio with New Injectable Products in the U.S	11/04
Baxter to Host First-Quarter 2024 Financial Results Conference Call for Investors	10/04
Pfizer, Baxter, Thermo Fisher, Others FTC Cautioned to Extend Merger Review Period	04/04
Baxter International Receives US FDA Clearance for Novum IQ Large Volume Infusion Pump	01/04
Baxter Announces U.S. FDA Clearance of Novum IQ Large Volume Infusion Pump and Dose IQ Safety Software, Advancing Connected and Intelligent Infusion Therapy	01/04
Baxter International Inc. Announces U.S. FDA Clearance of Novum IQ Large Volume Infusion Pump and Dose IQ Safety Software, Advancing Connected and Intelligent Infusion Therapy	01/04
Baxter International : 2023 Proxy Statement Supplement	28/03
Baxter to Host Annual Meeting of Stockholders in Virtual Format	27/03
Baxter International Files Definitive Proxy Statement with Securities and Exchange Commission	25/03
Baxter International Inc. Enters into Fourth Amendment to the Existing $4.0 Billion Term Loan Credit Facility	21/03
Baxter International Receives a Shareholder Proposal from John Chevedden	14/03
Dialysis providers gain as investors focus on cardiac benefits after Ozempic's latest data	05/03
Baxter International Now Considering Sale of Kidney Care Business to Private Equity Investors	05/03

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Baxter International Inc.

Aandelen

BAX

US0718131099

Andere talen

Filters